SEC Form 4 · accession 0001179110-15-001898
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg H Alton
Officer — EVP, Corp & Med Affairs
Period of report
Feb 2, 2015
Accepted (ET)
Feb 4, 2015 · 8:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 2, 2015 | M | 10,000 | $19.085 | A | 123,694 | D | |
| Common StockF3 | Feb 2, 2015 | S | 3,630 | $105.2028 | D | 120,064 | D | |
| Common StockF4 | Feb 2, 2015 | S | 6,270 | $106.0692 | D | 113,794 | D | |
| Common Stock | Feb 2, 2015 | S | 100 | $107.03 | D | 113,694 | D | |
| Common StockF5 | Feb 2, 2015 | S | 1,500 | $105.2666 | D | 112,194 | D | |
| Common StockF6 | Feb 2, 2015 | S | 500 | $106.352 | D | 111,694 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $19.085 | Feb 2, 2015 | M | 10,000 | D | — | Jan 20, 2021 | Common Stock | 10,000 | 54,375 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- F3Sale prices reported for the transactions reported here range from $104.72 to $105.62. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F4Sale prices reported for the transactions reported here range from $105.7424 to $106.5615. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F5Sale prices reported for the transactions reported here range from $104.94 to $105.92. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F6Sale prices reported for the transactions reported here range from $106.07 to $106.94. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.